Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 252-346-9 | CAS number: 35074-77-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Link to relevant study records
- Endpoint:
- toxicity to reproduction
- Data waiving:
- other justification
- Justification for data waiving:
- other:
- Reproductive effects observed:
- not specified
Reference
Effect on fertility: via oral route
- Endpoint conclusion:
- no study available
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Effects on developmental toxicity
Description of key information
In a developmental toxicity study conducted in albino rats no teratogenicity was observed. (BASF, 1978)
Link to relevant study records
- Endpoint:
- developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1978-06-29 to 1978-10-18
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: None GLP but equivalent to guideline study.
- Qualifier:
- according to guideline
- Guideline:
- other: WILSON, J.G., in: Teratology, Principles and Techniques; J.G. Wilson and J. Warkany eds., The University of Chicago Press, Chicago and London, 1965, pp. 265-277.
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: DAWSON, A.B., Stain Tech. 1 (1926), 123-124.
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: SALEWSKI, E.., Arch. exp. Path. Pharmak. 247 (1964), 367-368.
- Deviations:
- no
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 414 (Prenatal Developmental Toxicity Study)
- Deviations:
- no
- GLP compliance:
- no
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Female albino rats (Tif: RAIf (SPF)) obtained from a closed breeding colony
- Age at study initiation: 2 months
- Weight at study initiation: ca. 190 g
- Housing: Throughout the experiment the successfully mated females were kept in groups of 5 in Macrolon cages in an air-conditioned room.
- Diet: ad libitum, Nafag No. 890
- Water: ad libitum, tap water
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 ± 1
- Humidity (%): 60 ± 5
- Photoperiod (hrs dark / hrs light): 14/10 - Route of administration:
- oral: gavage
- Vehicle:
- CMC (carboxymethyl cellulose)
- Details on exposure:
- VEHICLE
- Amount of vehicle: 2 % solution from own stocks - Analytical verification of doses or concentrations:
- no
- Details on mating procedure:
- Before test start the female rats were mated overnight with males of proven fertility in a ratio of 1 male : 3 females. The day on which spermatozoa were found in the vaginal smear or a vaginal plug has occurred was designated as "Day 0" of pregnancy.
- Duration of treatment / exposure:
- Day 6 to day 15 of pregnancy
- Frequency of treatment:
- daily
- Duration of test:
- 21 days
- Remarks:
- Doses / Concentrations:
150, 750 and 2000 mg/kg bw/d
Basis:
nominal conc. - No. of animals per sex per dose:
- 25 female animals per dose
- Control animals:
- yes
- Details on study design:
- In order to determine the dose levels for the main study, a preliminary experiment was carried out on 10 fertilized albino rats at the dose of 2500 mg/kg, given orally by intubation from day 6 until day 15 of pregnancy, inclusive. The dams of this high dose group reacted to treatment by a marked decrease in body-weight gain and food consumption. So far as the progeny were concerned, a reduction in foetal average weight was noted.
- Maternal examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: daily examination
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: daily examination
BODY WEIGHT: Yes
- Time schedule: daily examination
FOOD CONSUMPTION: Yes
- Food consumption for each animal determined at a dose-related fashion.
- Time schedule: examinations on days 6, 11, 16 and 21
POST-MORTEM EXAMINATIONS: Yes
- Sacrifice on gestation day 21
- Organs examined: ovaries, uterus - Ovaries and uterine content:
- The ovaries and uterine content was examined after termination: Yes
Examinations included:
- Gravid uterus weight: No
- Number of corpora lutea: No
- Number of implantations: Yes
- Number of early resorptions: Yes
- Number of late resorptions: Yes - Fetal examinations:
- - External examinations: Yes: all per litter
- Soft tissue examinations: Yes: 1/3 live foetuses
- Skeletal examinations: Yes: 2/3 live foetuses
- Head examinations: No - Statistics:
- The Chi-square test was used together with the Yates correction to compare the sex ratios of the litters with the vehicle controls.
- Indices:
- No indices were determined.
- Historical control data:
- Yes
- Details on maternal toxic effects:
- Maternal toxic effects:yes
Details on maternal toxic effects:
Throughout the period of treatment food intake was reduced in the three dose groups. At the 750 mg/kg bw/d dose and the 2000 mg/kg bw/d dose the body weight gain was diminished, in addition.
The implantation rates were comparable for all groups. In one dam of the 750 and 2000 mg/kg bw/d dose group each haemorrhagic degeneration of implantation sites (deciduomata) was noted. One dam with deciduomata was observed among the rats of the cumulative control.
The rates of foetalethality (resorptions) were comparable for all groups. - Dose descriptor:
- NOAEL
- Effect level:
- 2 000 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Basis for effect level:
- other: developmental toxicity
- Dose descriptor:
- NOAEL
- Effect level:
- 150 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Basis for effect level:
- other: maternal toxicity
- Details on embryotoxic / teratogenic effects:
- Embryotoxic / teratogenic effects:yes
Details on embryotoxic / teratogenic effects:
The sex ratios of the foetuses were not significantly altered when compared with the vehicle control. At the highest dosing group the average weight of the foetuses was slightly but significantly diminished. The gross examination of the foetuses revealed one omphalocele in one foetus of the highest dosing group and the control group each. This type of malformation was also found in 2 out of 3533 foetuses of the historical control data.
No pathological changes of viscera were found in the experimental groups, including the vehicle control. Some anomalies were noted, however, in the historical control.
Regarding the skeletal assessment, the only clearcut deviation from the vehicle control is assumed to manifest in an increased number of not yet ossified phalangeal nuclei at the 2000 mg/kg bw/d dose. Some skeletal anomalies were observed in the historical control. - Abnormalities:
- not specified
- Developmental effects observed:
- not specified
Reference
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 2 000 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
- Quality of whole database:
- Scientifically acceptable and guideline compliant study report.
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Additional information
A developmental toxicity study was conducted in female Sprague-Dawley rats equivalent or similar to OECD guideline 414. In order to determine the dose levels for the main study, a preliminary experiment was carried out on 10 fertilized albino rats at the dose of 2500 mg/kg bw/d, given orally by intubation from day 6 until day 15 of pregnancy, inclusive. The dams of this high dose group reacted to treatment by a marked decrease in body weight gain and food consumption. So far as the progeny were concerned, a reduction in foetal average weight was noted.
On the basis of these results the dosage for the main study was selected at 150, 750 and 2000 mg/kg bw/d. Again, the compound was administered orally by intubation from day 6 until day 15 of pregnancy to 25 animals. During the period of treatment, general condition, weight gain and symptomatology were checked daily. Food consumption was noted on Days 6, 11, 16 and 21 of pregnancy. The rats of the three dose groups reacted to treatment by a reduction in food consumption at a dose related fashion. In both the 750 mg/kg bw/d and 2000 mg/kg bw/d dose groups body weight gain of the dams was diminished, in addition. The progeny of both the low dose group and the intermediate dose group were not found to be adversely affected by the treatment. The foetuses of the 2000 mg/kg bw/d dose group appeared to be slightly retarded in their physiological growth, as indicated by a decrease in average weight and a higher number of still unossified phalangeal nuclei as compared to the vehicle control. These slight effects on the embryo or foetus are assumed to be entirely non-specific and due to toxic effects on the dams. One instance of malformation (omphalocele) was noted each in the high-dose group and the vehicle control and considered to be of a spontaneous origin. This sort of malformation was also observed among the foetuses of the historical (cumulative) control. To summarize, the test substance did not exhibit either a teratogenic potential or an increased embryolethality rate in the albino rat under the conditions of the present experiment. A NOAEL for developmental toxicity of 2000 mg/kg bw/d was determined.
Justification for selection of Effect on developmental toxicity: via oral route:
Scientifically acceptable and guideline compliant study report.
Justification for classification or non-classification
Dangerous Substance Directive (67/548/EEC)
The available study is considered reliable and suitable for classification purposes under 67/548/EEC. As a result the substance does not need to be classified and labelled for developmental toxicity under Directive 67/548/EEC, as amended for the 31st time in Directive 2009/2/EC.
Classification, Labelling, and Packaging Regulation (EC) No 1272/2008
The available study is reliable and suitable for classification purposes under Regulation 1272/2008. As a result the substance does not need to be classified and labelled for developemental toxicity under Regulation (EC) No 1272/2008, as amended for the sixth time in Regulation EC No 605/2014.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.